Providence Willamette Falls Medical Center

Oregon City, Oregon, United States
Hospital in Oregon City, Oregon
1500 Division St, Oregon City, OR 97045
143 Beds

About Providence Willamette Falls Medical Center


Providence Willamette Falls Medical Center is a not-for-profit acute care hospital operated by Providence Health & Services in Oregon City, Oregon, United States. Established in 1954 as Doctors' Hospital, the hospital moved to its current location in 1961 and has 143 licensed beds at its 243,000-square-foot facility.
There are 143 beds in Providence Willamette Falls Medical Center.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Providence Willamette Falls Medical Center


During the past decade, Providence Willamette Falls Medical Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 83 clinical trials were completed, i.e. on average, 332% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 42 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis
2016-10-01
2017-08-01
Completed
74
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
2018-03-07
2019-02-05
Completed
385
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
2018-07-13
2020-09-09
Terminated
484
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
2018-05-01
2018-10-08
Completed
116
A Study Evaluating the Long-term Safety of VX-445 Combination Therapy
2019-08-09
2022-12-14
Completed
458
A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
2019-08-28
2020-06-12
Completed
271
Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy
2019-12-05
2022-12-16
Completed
251
A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)
2021-01-18
2022-07-14
Completed
69

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Providence Willamette Falls Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 52 trials, followed by "SWOG Cancer Research Network" with 34 trials sponsored, "Alliance for Clinical Trials in Oncology" with 28 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "GOG Foundation" with 4 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Willamette Falls Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 77 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 32 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Providence Willamette Falls Medical Center


According to Clinical.Site data, the most researched conditions in "Providence Willamette Falls Medical Center" are "Breast Cancer" (15 trials), "Lymphoma" (9 trials), "Recurrent Breast Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (6 trials). Many other conditions were trialed in "Providence Willamette Falls Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Providence Willamette Falls Medical Center


Most popular intervention types in "Providence Willamette Falls Medical Center" are "Drug" (107 trials), "Other" (85 trials), "Biological" (40 trials), "Procedure" (21 trials) and "Radiation" (9 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (49 trials), "Quality-of-Life Assessment" (23 trials), "Paclitaxel" (12 trials), "placebo" (11 trials) and "Questionnaire Administration" (10 trials). Other intervention names were less common.

Clinical Trials Genders at Providence Willamette Falls Medical Center


The vast majority of trials in "Providence Willamette Falls Medical Center" are 101 trials for "All" genders, 28 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Providence Willamette Falls Medical Center


Currently, there are NaN active trials in "Providence Willamette Falls Medical Center". undefined are not yet recruiting, 5 are recruiting, 66 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Providence Willamette Falls Medical Center, undefined suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Providence Willamette Falls Medical Center, 6 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status